Patent Assignment
Reel/Frame 064326/0977
Release of Security Interest
Recorded: 2023-07-20
Pages: 10
Assignor
HERCULES CAPITAL, INC.
Executed: 2023-07-20
Assignee
NABRIVA THERAPEUTICS GMBH
LEBERSTRASSEE 20, VIENNA, 1110, AUSTRIA
Covered Properties
(3)
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/023,880 →
Publication:
US 2018/0303842
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/277,143 →
Publication:
US 2019/0175603
Purification of Pleuromutilin
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Security Interest
Jan 18, 2019
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 048062/0807 →
Assignment of Assignor's Interest
Aug 1, 2019
From: HEILMAYER, WERNER; SPENCE, LEE; HINSMANN, PETER
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 049930/0721 →
First Supplement to Intellectual Property Security Agreement
Mar 20, 2020
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 052201/0503 →
Assignment of Assignor's Interest
Jan 9, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 069806/0458 →
Nunc Pro Tunc Assignment
Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →